Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,499 | -809 | -2,656 | -2,066 | -1,416 |
| Depreciation Amortization | 44 | 26 | 112 | 83 | 54 |
| Accounts receivable | -8 | 16 | -63 | -5 | 7 |
| Other Working Capital | -1,324 | 287 | 336 | 389 | 333 |
| Other Operating Activity | 18 | -22 | -498 | -468 | -414 |
| Operating Cash Flow | $-3,769 | $-501 | $-2,769 | $-2,067 | $-1,437 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -147 | -4 | -55 | -31 | -25 |
| Other Investing Activity | -147 | -8 | -295 | -31 | -25 |
| Investing Cash Flow | $-147 | $-8 | $-295 | $-31 | $-25 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,000 | N/A | 2,256 | 1,153 | 114 |
| Other Financing Activity | -947 | -104 | -828 | -358 | -89 |
| Financing Cash Flow | $4,053 | $-104 | $1,428 | $795 | $24 |
| Exchange Rate Effect | -7 | -1 | 27 | 23 | 28 |
| Beginning Cash Position | 865 | 865 | 2,474 | 2,474 | 2,474 |
| End Cash Position | 994 | 250 | 865 | 1,194 | 1,064 |
| Net Cash Flow | $130 | $-614 | $-1,609 | $-1,280 | $-1,410 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,769 | -501 | -2,769 | -2,067 | -1,437 |
| Free Cash Flow | -3,769 | -501 | -2,769 | -2,067 | -1,437 |